 |
|
The Pregnant EpilepticA Review and Recommendations
Georgia D. Montouris, MD;
Gerald M. Fenichel, MD;
L. William McLain, Jr, MD
Arch Neurol. 1979;36(10):601-603.
Abstract
• The major concerns in the pregnant epileptic patient are loss of seizure control and the teratogenic effects of antiepileptic drugs on the fetus. Loss of seizure control is usually caused by a progressive decline of antiepileptic plasma levels throughout pregnancy. This decline can be prevented by monthly dose adjustments based on plasma level determinations. Although infant malformations are a more prevalent outcome of the pregnancies of epileptics than of nonepileptics, the role of antiepileptic drugs in teratogenicity is not fully established. Only trimethadione has been convincingly linked to fetal malformation. Recommendations for the management of epilepsy in pregnancy are made.
Author Affiliations
From the Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tenn. Dr McLain is currently with the Department of Neurology, University of Minnesota, Minneapolis.
Footnotes
Accepted for publication Dec 31, 1978.
Reprint requests to Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN 37232 (Dr Fenichel).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Medical Illness and Pregnancy: An Annotated Bibliography of Recent Literature
ELLIOT et al.
ANN INTERN MED 1983;99:131-137.
ABSTRACT
Pregnancy increases reactivity of mice to phenobarbital
Middaugh et al.
Science 1983;220:534-536.
ABSTRACT
Neurology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
ANN INTERN MED 1983;98:421-426.
ABSTRACT
Neurology/ Internal Medicine
Dalessio
JAMA 1980;243:2193-2195.
ABSTRACT
|
